Drugs / CRD-102
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03217331 | Mar → Oct 2018 | heart failure | Cardiora Pty. Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CRD-102 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03217331 ↗ |
| Route | Oral | “administered twice daily orally” NCT03217331 ↗ |